1Meloxicam is the most used non-steroidal anti-inflammatory drug for managing post-operative pain in dogs. It is available both as injection liquid for use in vet practices and as oral suspension for home treatments. Typical treatment regimens include using meloxicam in combination of higher i.v. or p.o. initial dose followed by a lower p.o. maintenance dose for a few days.

ST18D is an injectable (s.c.) meloxicam silica-hydrogel depot for post-operative pain management in dogs. The slow-release formulation will provide pain relief for 3 – 5 days after operation.

We have results of the first PK study, market survey results (US, UK, Germany, France), and a development plan designed by an independent company available on request.

We are looking for an early co-development deal for the project.